National Cancer Institute; Notice of Closed Meeting, 24859 [E9-12201]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 99 / Tuesday, May 26, 2009 / Notices
organizations), our review and
evaluation of AOA will be conducted in
accordance with, but not necessarily
limited to, the following factors:
• The equivalency of AOA’s
standards for an ASC as compared with
CMS’ ASC conditions for coverage.
• AOA’s survey process to determine
the following:
—The composition of the survey team,
surveyor qualifications, and the
ability of the organization to provide
continuing surveyor training.
—The comparability of AOA’s processes
to those of State agencies, including
survey frequency, and the ability to
investigate and respond appropriately
to complaints against accredited
facilities.
—AOA’s processes and procedures for
monitoring ASCs found out of
compliance with AOA’s program
requirements. These monitoring
procedures are used only when AOA
identifies noncompliance. If
noncompliance is identified through
validation reviews, the State survey
agency monitors corrections as
specified at § 488.7(d).
—AOA’s capacity to report deficiencies
to the surveyed facilities and respond
to the facility’s plan of correction in
a timely manner.
—AOA’s capacity to provide us with
electronic data and reports necessary
for effective validation and
assessment of the organization’s
survey process.
—The adequacy of AOA’s staff and
other resources, and its financial
viability.
—AOA’s capacity to adequately fund
required surveys.
—AOA’s policies with respect to
whether surveys are announced or
unannounced, to assure that surveys
are unannounced.
—AOA’s agreement to provide us with
a copy of the most current
accreditation survey together with any
other information related to the
survey as we may require (including
corrective action plans).
IV. Collection of Information
Requirements
This document does not impose
information collection and
recordkeeping requirements.
Consequently, it need not be reviewed
by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 35).
V. Response to Comments
Because of the large number of public
comments we normally receive on
Federal Register documents, we are not
VerDate Nov<24>2008
20:08 May 22, 2009
Jkt 217001
able to acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified in the DATES section of
this preamble, and, when we proceed
with a subsequent document, we will
respond to the comments in the
preamble to that document.
(Catalog of Federal Domestic Assistance
Program No. 93.778, Medical Assistance
Program; No. 93.773 Medicare—Hospital
Insurance Program; and No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
Dated: April 30, 2009.
Charlene Frizzera,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. E9–12109 Filed 5–22–09; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
H—Clinical Groups.
Date: July 20–21, 2009.
Time: 8 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Timothy C. Meeker, MD,
PhD, Scientific Review Officer, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard, Room
8103, Bethesda, MD 20892. (301) 594–1279.
meekert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
24859
Cancer Control, National Institutes of Health,
HHS)
Dated: May 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–12201 Filed 5–22–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee, (HICPAC)
In accordance with section 10(a) (2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned committee:
Times and Dates: 9 a.m.–5 p.m., June 15,
2009. 9 a.m.–12 p.m., June 16, 2009.
Place: CDC, Tom Harkin Global
Communications Center (Building 19),
Auditorium B3, 1600 Clifton Road, Atlanta,
Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The Committee is charged with
providing advice and guidance to the
Secretary, the Assistant Secretary for Health,
the Director, CDC, and the Director, National
Center for Preparedness, Detection, and
Control of Infectious Diseases (NCPDCID),
regarding: (1) The practice of hospital
infection control; (2) strategies for
surveillance, prevention, and control of
infections (e.g., nosocomial infections),
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of guidelines and other
policy statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters to be Discussed: The agenda will
include a follow up discussion of Health and
Human Services Healthcare-Associated
Infections (HAI) elimination plan, Norovirus
Guideline, and Healthcare Personnel
Infection Control Guideline.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Wendy Vance, Committee Management
Specialist, Division of Healthcare Quality
Promotion, NCPDCID, CDC, l600 Clifton
Road, NE., Mailstop A–07, Atlanta, Georgia
30333 Telephone (404) 639–2891.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
E:\FR\FM\26MYN1.SGM
26MYN1
]]>Agencies
[Federal Register Volume 74, Number 99 (Tuesday, May 26, 2009)]
[Notices]
[Page 24859]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-12201]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Initial Review
Group, Subcommittee H--Clinical Groups.
Date: July 20-21, 2009.
Time: 8 a.m. to 8 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Timothy C. Meeker, MD, PhD, Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Boulevard, Room 8103, Bethesda, MD 20892. (301) 594-1279.
meekert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: May 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-12201 Filed 5-22-09; 8:45 am]
BILLING CODE 4140-01-P
